Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease (Q81093828)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2005

Language	Label	Description	Also known as
English	Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease	scientific article published on 01 November 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Philadelphia chromosome

1 reference

object named as

Philadelphia chromosome

2 August 2024

based on heuristic

inferred from title

author name string

Yanada M

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Naoe T

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Iida H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Sakamaki H

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Sakura T

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Kanamori H

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Kodera Y

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Okamoto S

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Kanda Y

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Sao H

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Asai O

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Nakai K

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Maruta A

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Kishi K

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Furukawa T

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Atsuta Y

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Yamamoto K

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Tanaka J

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Takahashi S

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

867-872

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16113659 AND SRC:MED&resulttype=core&format=json

5 January 2020

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic myeloablative transplantation for patients aged 50 years and over

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1705148

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81093828&oldid=2221027618"